phase 3 trial

Both vonoprazan 10 mg and 20 mg doses met the primary endpoint and showed highly statistically significant greater percentage of 24-hour heartburn free days as compared to placebo…

Alongside the TRIKAFTA trial for patients 12 and older, the team led by Edith Zemanick, MD, pediatric pulmonologist, a principal investigator of the study and associate professor of…

International team of researchers set out to see whether Lu-PSMA-617 was more effective than standard care and recruited 831 patients with metastatic castration-resistant prostate cancer…